16-27344903-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000418.4(IL4R):​c.244G>A​(p.Ala82Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00588 in 1,614,220 control chromosomes in the GnomAD database, including 321 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A82V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0091 ( 46 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 275 hom. )

Consequence

IL4R
NM_000418.4 missense

Scores

17

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: -2.73

Publications

11 publications found
Variant links:
Genes affected
IL4R (HGNC:6015): (interleukin 4 receptor) This gene encodes the alpha chain of the interleukin-4 receptor, a type I transmembrane protein that can bind interleukin 4 and interleukin 13 to regulate IgE production. The encoded protein also can bind interleukin 4 to promote differentiation of Th2 cells. A soluble form of the encoded protein can be produced by proteolysis of the membrane-bound protein, and this soluble form can inhibit IL4-mediated cell proliferation and IL5 upregulation by T-cells. Allelic variations in this gene have been associated with atopy, a condition that can manifest itself as allergic rhinitis, sinusitus, asthma, or eczema. Polymorphisms in this gene are also associated with resistance to human immunodeficiency virus type-1 infection. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2012]
IL4R Gene-Disease associations (from GenCC):
  • IgE responsiveness, atopic
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0023322105).
BP6
Variant 16-27344903-G-A is Benign according to our data. Variant chr16-27344903-G-A is described in ClinVar as [Benign]. Clinvar id is 3043783.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0091 (1387/152368) while in subpopulation EAS AF = 0.0433 (225/5192). AF 95% confidence interval is 0.0387. There are 46 homozygotes in GnomAd4. There are 937 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 46 Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL4RNM_000418.4 linkc.244G>A p.Ala82Thr missense_variant Exon 5 of 11 ENST00000395762.7 NP_000409.1 P24394-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL4RENST00000395762.7 linkc.244G>A p.Ala82Thr missense_variant Exon 5 of 11 1 NM_000418.4 ENSP00000379111.2 P24394-1

Frequencies

GnomAD3 genomes
AF:
0.00911
AC:
1387
AN:
152250
Hom.:
46
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000434
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00327
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.0432
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.0850
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00228
Gnomad OTH
AF:
0.00813
GnomAD2 exomes
AF:
0.0127
AC:
3191
AN:
251248
AF XY:
0.0119
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.00109
Gnomad EAS exome
AF:
0.0371
Gnomad FIN exome
AF:
0.0863
Gnomad NFE exome
AF:
0.00233
Gnomad OTH exome
AF:
0.0129
GnomAD4 exome
AF:
0.00555
AC:
8107
AN:
1461852
Hom.:
275
Cov.:
40
AF XY:
0.00541
AC XY:
3934
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.00631
AC:
282
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00138
AC:
36
AN:
26136
East Asian (EAS)
AF:
0.0506
AC:
2007
AN:
39700
South Asian (SAS)
AF:
0.00121
AC:
104
AN:
86258
European-Finnish (FIN)
AF:
0.0836
AC:
4463
AN:
53388
Middle Eastern (MID)
AF:
0.000867
AC:
5
AN:
5766
European-Non Finnish (NFE)
AF:
0.000796
AC:
885
AN:
1112006
Other (OTH)
AF:
0.00528
AC:
319
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
426
852
1278
1704
2130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00910
AC:
1387
AN:
152368
Hom.:
46
Cov.:
32
AF XY:
0.0126
AC XY:
937
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000433
AC:
18
AN:
41592
American (AMR)
AF:
0.00327
AC:
50
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00202
AC:
7
AN:
3472
East Asian (EAS)
AF:
0.0433
AC:
225
AN:
5192
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.0850
AC:
903
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00228
AC:
155
AN:
68032
Other (OTH)
AF:
0.00804
AC:
17
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
69
138
208
277
346
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00332
Hom.:
11
Bravo
AF:
0.00299
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000698
AC:
6
ExAC
AF:
0.0111
AC:
1342

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

IL4R-related disorder Benign:1
Aug 21, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.0020
DANN
Benign
0.50
DEOGEN2
Benign
0.030
.;T;T;.;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0069
N
LIST_S2
Benign
0.56
.;.;T;T;T
MetaRNN
Benign
0.0023
T;T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-2.7
PrimateAI
Benign
0.25
T
PROVEAN
Benign
0.020
N;N;N;N;.
REVEL
Benign
0.014
Sift
Benign
0.81
T;T;T;T;.
Sift4G
Benign
0.19
T;T;T;T;T
Polyphen
0.13
.;B;B;.;.
Vest4
0.027, 0.030, 0.018
MPC
0.12
ClinPred
0.00097
T
GERP RS
-5.4
PromoterAI
0.036
Neutral
Varity_R
0.055
gMVP
0.28
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144651842; hg19: chr16-27356224; COSMIC: COSV50146925; COSMIC: COSV50146925; API